文献速递药物相互作用治疗药物监测与药物基因组学肝肾功能剂量调整

环孢素与替格瑞洛合用可能导致环孢素暴露升高:一例49岁男性病例报告

Co-administration of cyclosporine and ticagrelor may lead to a higher exposure to cyclosporine: a case report of a 49-year-old man.
PubMed 文献 · Br J Clin Pharmacol · 2017-10-18

本文报告一例49岁稳定肾移植男性,长期环孢素谷浓度稳定,因不稳定型心绞痛加用替格瑞洛后环孢素谷浓度升高,停用替格瑞洛后考虑为药物相互作用。机制可能为替格瑞洛抑制CYP3A4和P-糖蛋白,提示临床应密切监测环孢素血药浓度。

要点

  • 替格瑞洛可能通过抑制CYP3A4和P-糖蛋白升高环孢素暴露。
  • 合用时应密切监测环孢素血药浓度以避免过量。
  • 该相互作用仅为病例报告,需药代动力学研究进一步验证。

核心结论

  • 环孢素与替格瑞洛合用可能导致环孢素暴露升高,临床应警惕此潜在相互作用。

研究设计与样本

  • 单例病例报告:49岁男性,稳定肾移植,长期环孢素谷浓度稳定,因不稳定型心绞痛接受替格瑞洛治疗。

主要发现

  • 加用替格瑞洛后环孢素谷浓度升高,停用替格瑞洛后考虑相互作用,且无其他可解释环孢素暴露升高的原因。

关键数值与推荐

  • 替格瑞洛通过抑制CYP3A4和P-糖蛋白导致环孢素暴露升高;需密切监测环孢素血清浓度以避免过量。

临床怎么用

  • 临床医生应知晓环孢素与替格瑞洛的潜在相互作用,合用期间密切监测环孢素血药浓度。

局限性

  • 仅为单例病例报告,需药代动力学研究进一步验证环孢素与替格瑞洛的相互作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ADVERSE EVENT: A drug interaction leading to higher exposure to cyclosporine. DRUGS IMPLICATED: Cyclosporine and ticagrelor. THE PATIENT: A 49-year-old man with a stable renal graft, managed with cyclosporine with stable trough blood concentrations for several years, was treated with ticagrelor for unstable angina pectoris. EVIDENCE THAT LINKS THE DRUG TO THE EVENT: The timeline was consistent with the appearance of an interaction, the interaction was confirmed by an increase in trough concentration of cyclosporine, and there were no alternative causes that by themselves could have caused the increase in cyclosporine exposure. MANAGEMENT: Cessation of ticagrelor. MECHANISM: Inhibition of CYP3A4 and P-glycoprotein by ticagrelor. IMPLICATIONS FOR THERAPY: Clinicians should be aware of this potential interaction as ticagrelor is frequently prescribed in individuals using cyclosporine. Close monitoring of cyclosporine serum concentrations is warranted to avoid overdosing of cyclosporine. A pharmacokinetic study is needed to further examine the probable interaction between cyclosporine and ticagrelor.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. van Sloten TT, de Klaver PAG, van den Wall Bake AWL, et al. Co-administration of cyclosporine and ticagrelor may lead to a higher exposure to cyclosporine: a case report of a 49-year-old man. Br J Clin Pharmacol. 2017. PMID: 28891590. doi:10.1111/bcp.13433

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。